• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Bruce Sherman: Adding Nuance Can Make Value-Based Insurance Design More Impactful for Employers

Video

Making benefit design more nuanced through the inclusion of employee variables could help increase the impact of value-based insurance design for employers, said Bruce Sherman, MD, chief medical officer of the National Alliance of Healthcare Purchaser Coalitions.

Making benefit design more nuanced through the inclusion of employee variables could help increase the impact of value-based insurance design for employers, said Bruce Sherman, MD, chief medical officer of the National Alliance of Healthcare Purchaser Coalitions.

Transcript

How is value-based insurance design looking among employers? Are they interested in it?

There’s still a lot we don’t know about value-based insurance design, and as much as it seems like a great idea, and I think operationally it is for the right people, I think the impact we’re seeing is not as great as it potentially can be, in that the structure of value-based insurance design as a one-size-fits-all offering for everyone may not be as impactful as perhaps more nuanced, to use a Mark Fendrick word, as nuanced a delivery as perhaps thinking about more advanced, admittedly complicated or potentially complicated, approaches to value-based insurance design. It could be for example incorporating wage or household income as a variable in benefit design or value-based insurance design structure.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.